Shigeo Murayama

CSF p-tau181 increases in patients with neuronal intranuclear inclusion disease without amyloid burden

A. Tokumaru, S. Murayama, H. Ishiura, 2022, medRxiv.

Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease

K. Oda, K. Ishiwata, K. Ishibashi, 2009, Acta neurologica Scandinavica.